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Parkinson´s disease (PD) is the second most common
neurodegenerative disorder. It aﬀects over half a million
individuals in the U.S., with another 50,000 diagnosed
every year. PD is characterized by motor dysfunction
caused by a progressive loss of dopaminergic neurons.
Currently, there are no treatments that slow the progression
of the disease, which highlights the need for the
development of new therapies.
High content screening (HCS) is a drug discovery method
that could be leveraged in cellular models of PD to assess the
therapeutic viability of thousands of compounds. However,
HCS is challenging as it requires rapid analysis of large
volumes of data from images of fluorescently labeled cells.
In our study, carried out in the laboratory of Dr. Chris
Rochet, we are developing an automated protocol for
use in HCS. Our HCS will monitor cellular uptake of
fluorescently labeled, misfolded protein aggregates called
ﬁbrillar seeds, which promote protein accumulation and

clumping. Fibrillar seeds are believed to be the species
responsible for the propagation of neuropathology in the
brains of PD patients by inducing abnormal protein folding
and aggregation in neurons, as is also true for other
neurodegenerative diseases. Synthetic preformed ﬁbrils
(PFFs) labeled with fluorescent tags are administered
to neuron cell cultures, and speciﬁc uptake of these
ﬁbrils in primary midbrain neurons is monitored (see
image). Recent plugins developed within ImageJ, an
image analysis program, have been used to automatically
recognize regions of co-localized fluorescence and
calculate average intensity from these regions. We are
designing fluorescence-based methods and image analysis
plugins that can be used to visualize and quantify the
presence of PFFs in the interior of the cell. Our HCS
approach will be used to identify protective compounds
with the potential to prevent PD progression.
Graduate student mentor Sayan Dutta writes: “Ryan’s
research addresses a key piece of a bigger puzzle of ﬁnding
eﬀective drug molecules to slow down Parkinson’s disease.
His current eﬀorts in designing a ﬂuorescent probe and
image analysis algorithm are making our high content
screening project move forward signiﬁcantly.”
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Evidence of aSyn PFF uptake in primary midbrain neurons. (Left) Transmission electron microscopy images of fibrils formed by
unmodified human WT aSyn; scale bar = 200 nm. (Right) Primary midbrain cultures transduced with virus-encoding RFP downstream of
the neuron-specific synapsin promoter were treated with PFFs derived from recombinant human WT aSyn labeled with Alexa 488. After
24 hrs, the cultures were treated with trypan blue for 15 min to quench extracellular fluorescence and imaged via confocal microscopy.
Green fluorescent puncta corresponding to internalized, Alexa 488-labeled aSyn were detected in neurons that appear red because of
RFP expression (the yellow color corresponds to colocalized green and red signals). (Image retrieved with help of Dr. Ranjan Sengupta
and Sayan Dutta.)
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